2614W94

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug Name2614W94
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase A inhibitors
TargetsMonoamine oxidase A
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBurroughs Wellcome
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBurroughs Wellcome
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A